FDA.reportPublic FDA data

SODIUM CHLORIDE

Substance profile for UNII 451W47IQ8X, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for SODIUM CHLORIDE
Structure render from NCI/CADD chemical resolver

Substance Identity#

UNII
451W47IQ8X
Preferred term
SODIUM CHLORIDE
Registry number
7647-14-5
EC number
231-598-3
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
Cl.Na
Chemical structure for SODIUM CHLORIDE
Structure render from NCI/CADD chemical resolver

Chemical And Database Identifiers#

InChIKey
FAPWRFPIFSIZLT-UHFFFAOYSA-M
SMILES
[Na+].[Cl-]
RxCUI
9863
PubChem
0
NCIt
C29974
INN ID
4155

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem InChIKey SearchFAPWRFPIFSIZLT-UHFFFAOYSA-Mpubchem.ncbi.nlm.nih.gov/#query=FAPWRFPIFSIZLT-UHFFFAOYSA-M
RxNorm9863mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=9863
NCI ThesaurusC29974ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C29974
FDA Substance Registration System451W47IQ8Xprecision.fda.gov/uniisearch/srs/unii/451W47IQ8X
European Community number231-598-3commonchemistry.cas.org/results?q=231-598-3

DailyMed Socrata Ingredients#

Type, DailyMed label, SPL version table
TypeDailyMed labelSPL version
ACTIVE INGREDIENTf6113982-e3b7-4f42-ae6f-65374f00c7fa8
INACTIVE INGREDIENTf6113982-e3b7-4f42-ae6f-65374f00c7fa8
INACTIVE INGREDIENTThese highlights do not include all the information needed to use donepezil hydrochloride orally disintegrating tablets USP safely and effectively. See full prescribing information for donepezil hydrochloride orally disintegrating tablets USP. DONEPEZIL hydrochloride orally disintegrating tablets, USP Initial U.S. Approval: 199631
INACTIVE INGREDIENT3bc870c2-e1db-44ca-9552-ea5981fd3c3310
ACTIVE INGREDIENT3bc870c2-e1db-44ca-9552-ea5981fd3c3310
INACTIVE INGREDIENT2912a0e7-6bcf-4b08-b67e-6a271e8ae31111
INACTIVE INGREDIENTcbd3b7dc-da04-4497-be3c-b94363d6876f20
ACTIVE INGREDIENTcbd3b7dc-da04-4497-be3c-b94363d6876f20
INACTIVE INGREDIENT8dd7ab8f-2cb0-4600-9f57-ab5cef17155910
ACTIVE INGREDIENT8dd7ab8f-2cb0-4600-9f57-ab5cef17155910
ACTIVE INGREDIENT0d52ee7d-a955-4263-b53b-b697c3fa013d8
INACTIVE INGREDIENT0d52ee7d-a955-4263-b53b-b697c3fa013d8
INACTIVE INGREDIENTDrug Facts8
INACTIVE INGREDIENTDrug Facts7
INACTIVE INGREDIENT9665e134-2343-493d-9bbe-7b3dc577eb017
INACTIVE INGREDIENTFuture resist Foundation Broad Spectrum SPF 20 Truffle8
INACTIVE INGREDIENT0222f7ec-86ae-474d-ae9a-8ca1b98938a312
INACTIVE INGREDIENTDrug Facts11
INACTIVE INGREDIENTcdc7af8a-2c09-43e5-b873-cf3eb576c2128
INACTIVE INGREDIENT611798eb-4004-40e8-b7ff-3451362539758
INACTIVE INGREDIENTOxytocin 10 USP Units Added to 0.9% Sodium Chloride 1,000 mL Bag8
INACTIVE INGREDIENTThese highlights do not include all the information needed to use RECOTHROM safely and effectively. See full prescribing information for RECOTHROM. RECOTHROM, Thrombin topical (Recombinant) Lyophilized Powder for Solution - For Topical Use Only Initial U.S. Approval: 20088
INACTIVE INGREDIENTFentanyl Citrate 2 mcg/mL & Bupivacaine HCl 0.125% in 0.9% Sodium Chloride 250 mL Bag8
INACTIVE INGREDIENTThese highlights do not include all the information needed to use FORTICAL ® safely and effectively. See full prescribing information for FORTICAL. FORTICAL ® (calcitonin-salmon [rDNA origin]) Nasal Spray for intranasal use Initial U.S. Approval: 200510
INACTIVE INGREDIENTHeparin Sodium 10 USP Units/mL in 0.9% Sodium Chloride 3 mL Syringe9
INACTIVE INGREDIENTMidazolam HCl 1 mg/mL in 0.9% Sodium Chloride 2 mL Syringe7
INACTIVE INGREDIENTcb93958f-5c64-4aae-89f1-d5b5048baf6f8
INACTIVE INGREDIENTea4d9094-1aca-4c0f-a67d-7276a9fd591b9
ACTIVE INGREDIENTea4d9094-1aca-4c0f-a67d-7276a9fd591b9
INACTIVE INGREDIENTThese highlights do not include all the information needed to use Sumavel DosePro safely and effectively. See full prescribing information for Sumavel DosePro. Sumavel DosePro (sumatriptan injection), for subcutaneous use Initial U.S. Approval: 199213
INACTIVE INGREDIENTThese highlights do not include all the information needed to use epirubicin hydrochloride injection safely and effectively. See full prescribing information for epirubicin hydrochloride injection. EPIRUBICIN Hydrochloride Injection for intravenous use Initial U.S. Approval: 199912
INACTIVE INGREDIENTKids Cold and Mucus Relief9
INACTIVE INGREDIENT0ef40acf-0c28-42a9-a0a8-45c13abb40f413
INACTIVE INGREDIENTdad188ee-d2b6-4529-a42b-2cf7746dcd1813
INACTIVE INGREDIENTAnti Bacterial Liquid Hand Soap7
ACTIVE INGREDIENTDrug Facts7
INACTIVE INGREDIENTDrug Facts7
INACTIVE INGREDIENT5678be04-5e19-4c87-8eca-5222b849660e10
ACTIVE INGREDIENT5678be04-5e19-4c87-8eca-5222b849660e10
INACTIVE INGREDIENTeb2b27ce-332a-48c1-9ae4-e2b5c2b11bb19
INACTIVE INGREDIENT3d15d591-76d5-454c-b491-3d2406710c4b8
INACTIVE INGREDIENT7c7431eb-93e0-4d79-a995-27edbdacfb469
INACTIVE INGREDIENTLong Last Makeup10
INACTIVE INGREDIENTSpotless Cleanser16
INACTIVE INGREDIENTAnectine® (Succinylcholine Chloride Injection, USP)12
INACTIVE INGREDIENTa51fc004-9538-4e67-8f49-002babe17f9e9
INACTIVE INGREDIENTOily Hair Dandruff Shampoo9
INACTIVE INGREDIENTDrug Facts17
INACTIVE INGREDIENTSUN SAVVY SOLAR SHIELD SPF 2012
INACTIVE INGREDIENTThese highlights do not include all the information needed to use Medroxyprogesterone Acetate Injectable Suspension, USP safely and effectively. See full prescribing information for Medroxyprogesterone Acetate Injectable Suspension, USP. Medroxyprogesterone Acetate Injectable Suspension, USP, for intramuscular use Initial U.S. Approval: 19597
INACTIVE INGREDIENTDrug Facts8
INACTIVE INGREDIENTDrug Facts7
INACTIVE INGREDIENTDrug Facts9
INACTIVE INGREDIENTDrug Facts12
INACTIVE INGREDIENTDrug Facts7
INACTIVE INGREDIENTLeuprolide Acetate Injection13
INACTIVE INGREDIENTBuffered Eye-Lert12
INACTIVE INGREDIENTSterile Isotonic Buffered Genuine Eyewash10
INACTIVE INGREDIENT50 Person ANSI13
INACTIVE INGREDIENTARC FIRST AID Contains 303 PIECES HARDCASE13
INACTIVE INGREDIENTFIRST AID Contains 101 PIECES HARDCASE12
INACTIVE INGREDIENTFIRST AID Contains 101 PIECES11
INACTIVE INGREDIENTFIRST AID Contains 303 PIECES11
INACTIVE INGREDIENTGENUINE FIRST AID Emergency Preparedness Contains 167 Pieces11
INACTIVE INGREDIENTGENUINE FIRST AID Emergency Preparedness Contains 167 PIECES HARDCASE11
INACTIVE INGREDIENTMedium Cuts & Scratches11
INACTIVE INGREDIENT10Person ANSI10
INACTIVE INGREDIENTFIRST AID Contains 303 PIECES HARDCASE10
INACTIVE INGREDIENTFIRST AID Contains 404 PIECES10
INACTIVE INGREDIENTARC FIRST AID Contains 101 PIECES7
INACTIVE INGREDIENTARC FIRST AID Emergency Preparedness Contains 167 PIECES HARDCASE7
INACTIVE INGREDIENTRECOMBINATE [Antihemophilic Factor (Recombinant)]7
INACTIVE INGREDIENTPacific Antibacterial Hand Soap Drug Facts271
INACTIVE INGREDIENTPacific Antibacterial Hand Soap Drug Facts265
INACTIVE INGREDIENTPacific Antibacterial Hand Soap Drug Facts263
INACTIVE INGREDIENTPacific Antibacterial Hand Soap Drug Facts267
INACTIVE INGREDIENTONDANSETRON INJECTION [CARDINAL HEALTH]188557104
INACTIVE INGREDIENTTEMPRA (ACETAMINOPHEN) SYRUP [BRISTOL-MYERS SQUIBB DE MEXICO, S. DE R.L. DE C.V.]201509
INACTIVE INGREDIENTGENTAMICIN SULFATE SOLUTION/ DROPS [LAKE ERIE MEDICAL & SURGICAL SUPPY DBA QUALITY CARE PRODUCTS LLC]3884
INACTIVE INGREDIENTNEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE (NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE) SUSPENSION [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3864
INACTIVE INGREDIENTPOLYMYXIN B SULFATE AND TRIMETHOPRIM (POLYMYXIN B SULFATE AND TRIMETHOPRIM SULFATE) SOLUTION/ DROPS [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3852
INACTIVE INGREDIENTPATADAY (OLOPATADINE HYDROCHLORIDE) SOLUTION/ DROPS [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3728
INACTIVE INGREDIENTARTIFICIAL TEARS (POLYVINYL ALCOHOL) SOLUTION/ DROPS [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3700
INACTIVE INGREDIENTGENTAMICIN SULFATE SOLUTION/ DROPS [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3642
INACTIVE INGREDIENTHUMIRA (ADALIMUMAB) KIT HUMIRA (ADALIMUMAB) INJECTION, SOLUTION [ABBVIE INC.]1805
INACTIVE INGREDIENTKALETRA (LOPINAVIR AND RITONAVIR) TABLET, FILM COATED KALETRA (LOPINAVIR AND RITONAVIR) SOLUTION [ABBVIE INC.]1567
INACTIVE INGREDIENTENBREL (ETANERCEPT) SOLUTION ENBREL (ETANERCEPT) KIT [IMMUNEX CORPORATION]165
INACTIVE INGREDIENTVECTIBIX (PANITUMUMAB) SOLUTION [AMGEN INC]147
INACTIVE INGREDIENTARANESP (DARBEPOETIN ALFA) INJECTION, SOLUTION ARANESP (DARBEPOETIN ALFA) SOLUTION [AMGEN INC]138
INACTIVE INGREDIENTEPOGEN (EPOETIN ALFA) SOLUTION [AMGEN INC]121
INACTIVE INGREDIENTRELISTOR (METHYLNALTREXONE BROMIDE) KIT RELISTOR (METHYLNALTREXONE BROMIDE) INJECTION, SOLUTION [SALIX PHARMACEUTICALS, INC.]42
INACTIVE INGREDIENTEXALGO (HYDROMORPHONE HYDROCHLORIDE) TABLET, EXTENDED RELEASE [MALLINCKRODT, INC]36
INACTIVE INGREDIENTCUROSURF (PORACTANT ALFA) SUSPENSION [CHIESI USA, INC.]34
INACTIVE INGREDIENTERBITUX (CETUXIMAB) SOLUTION [IMCLONE LLC]34
INACTIVE INGREDIENTZYVOX (LINEZOLID) INJECTION, SOLUTION ZYVOX (LINEZOLID) TABLET, FILM COATED ZYVOX (LINEZOLID) SUSPENSION [PHARMACIA AND UPJOHN COMPANY]33
ACTIVE INGREDIENTMOVIPREP (POLYETHYLENE GLYCOL 3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, ASCORBIC ACID, SODIUM ASCORBATE) KIT [SALIX PHARMACEUTICALS, INC.]30
INACTIVE INGREDIENTSKIN CAVIAR FOUNDATION SUNSCREEN SPF 15 - AMBER BEIGE (OCTINOXATE 6.0%) LOTION [LA PRAIRIE, INC]30
INACTIVE INGREDIENTSKIN CAVIAR FOUNDATION SUNSCREEN SPF 15 - BUFF (OCTINOXATE 6.0%) LOTION [LA PRAIRIE, INC]30
INACTIVE INGREDIENTSKIN CAVIAR FOUNDATION SUNSCREEN SPF 15 - CARAMEL BEIGE (OCTINOXATE 6.0%) LOTION [LA PRAIRIE, INC]30
INACTIVE INGREDIENTSKIN CAVIAR FOUNDATION SUNSCREEN SPF 15 - CREME PECHE (OCTINOXATE 6.0%) LOTION [LA PRAIRIE, INC]30
INACTIVE INGREDIENTSKIN CAVIAR FOUNDATION SUNSCREEN SPF 15 - GOLDEN BEIGE (OCTINOXATE 6.0%) LOTION [LA PRAIRIE, INC]30
INACTIVE INGREDIENTSKIN CAVIAR FOUNDATION SUNSCREEN SPF 15 - HONEY BEIGE (OCTINOXATE 6.0%) LOTION [LA PRAIRIE, INC]30
INACTIVE INGREDIENTSKIN CAVIAR FOUNDATION SUNSCREEN SPF 15 - MOCHA (OCTINOXATE 6.0%) LOTION [LA PRAIRIE, INC]30
INACTIVE INGREDIENTSKIN CAVIAR FOUNDATION SUNSCREEN SPF 15 - PECHE (OCTINOXATE 6.0%) LOTION [LA PRAIRIE, INC]30
INACTIVE INGREDIENTSKIN CAVIAR FOUNDATION SUNSCREEN SPF 15 - PORCELAINE BLUSH (OCTINOXATE 6.0%) LOTION [LA PRAIRIE, INC]30
INACTIVE INGREDIENTSKIN CAVIAR FOUNDATION SUNSCREEN SPF 15 - SOFT IVORY (OCTINOXATE 6.0%) LOTION [LA PRAIRIE, INC]30
INACTIVE INGREDIENTSKIN CAVIAR FOUNDATION SUNSCREEN SPF 15 - SOLEIL BEIGE (OCTINOXATE 6.0%) LOTION [LA PRAIRIE, INC]30
INACTIVE INGREDIENTSKIN CAVIAR FOUNDATION SUNSCREEN SPF 15 - SOLEIL PECHE (OCTINOXATE 6.0%) LOTION [LA PRAIRIE, INC]30
INACTIVE INGREDIENTSKIN CAVIAR FOUNDATION SUNSCREEN SPF 15 - WARM BEIGE (OCTINOXATE 6.0%) LOTION [LA PRAIRIE, INC]30
INACTIVE INGREDIENTSKIN CAVIAR FOUNDATION SUNSCREEN SPF 15 - WARM IVORY (OCTINOXATE 6.0%) LOTION [LA PRAIRIE, INC]30
INACTIVE INGREDIENTSKIN CAVIAR FOUNDATION SUNSCREEN SPF 15 -TENDER IVORY (OCTINOXATE 6.0%) LOTION [LA PRAIRIE, INC]30
INACTIVE INGREDIENTSKIN CAVIAR FOUNDATION SUNSCREEN SPF 15 -WARM LINEN (OCTINOXATE 6.0%) LOTION [LA PRAIRIE, INC]30
INACTIVE INGREDIENTSKIN CAVIAR FOUNDATION SUNSCREEN SPF 15 - PETAL (OCTINOXATE 6.0%) LOTION [LA PRAIRIE, INC]29
INACTIVE INGREDIENTZOSTAVAX (ZOSTER VACCINE LIVE) INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION STERILE DILUENT (STERILE WATER) INJECTION [MERCK SHARP & DOHME CORP.]28
INACTIVE INGREDIENTPRECEDEX (DEXMEDETOMIDINE HYDROCHLORIDE) INJECTION, SOLUTION PRECEDEX (DEXMEDETOMIDINE HYDROCHLORIDE) INJECTION, SOLUTION, CONCENTRATE [HOSPIRA, INC.]27
INACTIVE INGREDIENTAVELOX (MOXIFLOXACIN HYDROCHLORIDE) INJECTION, SOLUTION AVELOX (MOXIFLOXACIN HYDROCHLORIDE) TABLET, FILM COATED [SCHERING PLOUGH CORPORATION]26
INACTIVE INGREDIENTPEGASYS (PEGINTERFERON ALFA-2A) KIT PEGASYS (PEGINTERFERON ALFA-2A) INJECTION, SOLUTION [GENENTECH, INC.]26
INACTIVE INGREDIENTTYSABRI (NATALIZUMAB) INJECTION [ELAN PHARMACEUTICALS, INC.]26
INACTIVE INGREDIENTVIMPAT (LACOSAMIDE) TABLET, FILM COATED VIMPAT (LACOSAMIDE) KIT VIMPAT (LACOSAMIDE) INJECTION VIMPAT (LACOSAMIDE) SOLUTION [UCB, INC.]26
INACTIVE INGREDIENTBOTOX (ONABOTULINUMTOXINA) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ALLERGAN, INC. ]24

Inactive Ingredient Database#

Browse recovered IID releases and source provenance.

Current IID rows for UNII 451W47IQ8X page 1 of 2 · 134 matching rows.

Ingredient, UNII, CAS table
IngredientUNIICASDosage formRoutePotencyMaximum daily exposure
SODIUM CHLORIDE451W47IQ8X7647145SOLUTIONAURICULAR (OTIC)18 mg
SODIUM CHLORIDE451W47IQ8X7647145SOLUTION/ DROPSAURICULAR (OTIC)18 mg
SODIUM CHLORIDE451W47IQ8X7647145SUSPENSIONAURICULAR (OTIC)0.9 %w/v
SODIUM CHLORIDE451W47IQ8X7647145SUSPENSION/ DROPSAURICULAR (OTIC)3 mg
SODIUM CHLORIDE451W47IQ8X7647145INJECTIONDENTAL0.4 %w/v
SODIUM CHLORIDE451W47IQ8X7647145POWDER, DENTIFRICEDENTAL0.03 mg/mg
SODIUM CHLORIDE451W47IQ8X7647145INJECTIONENDOTRACHEAL68 mg
SODIUM CHLORIDE451W47IQ8X7647145POWDER, FOR SUSPENSIONENDOTRACHEAL46.76 mg
SODIUM CHLORIDE451W47IQ8X7647145SUSPENSIONENDOTRACHEAL7.6 mg
SODIUM CHLORIDE451W47IQ8X7647145INJECTIONEPIDURAL648 mg
SODIUM CHLORIDE451W47IQ8X7647145INJECTION, SOLUTIONEPIDURAL3535 mg
SODIUM CHLORIDE451W47IQ8X7647145INJECTION, SUSPENSION, LIPOSOMALEPIDURAL11 mg
SODIUM CHLORIDE451W47IQ8X7647145SOLUTIONEPIDURAL0.9 %w/v
SODIUM CHLORIDE451W47IQ8X7647145INJECTIONINFILTRATION648 mg
SODIUM CHLORIDE451W47IQ8X7647145INJECTION, SOLUTIONINFILTRATION3535 mg
SODIUM CHLORIDE451W47IQ8X7647145INJECTIONINTRA-ARTERIAL278 mg
SODIUM CHLORIDE451W47IQ8X7647145INJECTION, POWDER, FOR SOLUTIONINTRA-ARTERIAL1.35 mg
SODIUM CHLORIDE451W47IQ8X7647145INJECTION, SOLUTIONINTRA-ARTERIAL278 mg
SODIUM CHLORIDE451W47IQ8X7647145INJECTIONINTRA-ARTICULAR26 mg
SODIUM CHLORIDE451W47IQ8X7647145INJECTION, POWDER, FOR SUSPENSIONINTRA-ARTICULAR45 mg
SODIUM CHLORIDE451W47IQ8X7647145INJECTION, SUSPENSIONINTRA-ARTICULAR26 mg
SODIUM CHLORIDE451W47IQ8X7647145INJECTIONINTRABURSAL9 mg
SODIUM CHLORIDE451W47IQ8X7647145INJECTIONINTRACARDIAC70 mg
SODIUM CHLORIDE451W47IQ8X7647145INJECTIONINTRACAUDAL210 mg
SODIUM CHLORIDE451W47IQ8X7647145INJECTION, SOLUTIONINTRACAUDAL210 mg
SODIUM CHLORIDE451W47IQ8X7647145INJECTIONINTRACAVITARY0.82 %w/v
SODIUM CHLORIDE451W47IQ8X7647145INJECTIONINTRADERMAL7 mg
SODIUM CHLORIDE451W47IQ8X7647145INJECTIONINTRALESIONAL0.9 %w/v
SODIUM CHLORIDE451W47IQ8X7647145INJECTION, SUSPENSIONINTRALESIONAL13 mg
SODIUM CHLORIDE451W47IQ8X7647145INJECTIONINTRAMUSCULAR1486 mg
SODIUM CHLORIDE451W47IQ8X7647145INJECTION, POWDER, FOR SOLUTIONINTRAMUSCULAR226 mg
SODIUM CHLORIDE451W47IQ8X7647145INJECTION, POWDER, LYOPHILIZED, FOR SOLUTIONINTRAMUSCULAR360 mg
SODIUM CHLORIDE451W47IQ8X7647145INJECTION, SOLUTIONINTRAMUSCULAR1486 mg
SODIUM CHLORIDE451W47IQ8X7647145INJECTION, SOLUTION, CONCENTRATEINTRAMUSCULAR0.86 %w/v
SODIUM CHLORIDE451W47IQ8X7647145INJECTION, SUSPENSIONINTRAMUSCULAR26 mg
SODIUM CHLORIDE451W47IQ8X7647145INJECTION, SUSPENSION, EXTENDED RELEASEINTRAMUSCULAR24 mg
SODIUM CHLORIDE451W47IQ8X7647145LIQUIDINTRAMUSCULAR17 mg
SODIUM CHLORIDE451W47IQ8X7647145SOLUTIONINTRAMUSCULAR90 mg
SODIUM CHLORIDE451W47IQ8X7647145SUSPENSIONINTRAMUSCULAR9 mg
SODIUM CHLORIDE451W47IQ8X7647145INJECTION, SOLUTION, CONCENTRATEINTRAOCULAR0.86 %w/v
SODIUM CHLORIDE451W47IQ8X7647145SOLUTIONINTRAOCULAR320 mg
SODIUM CHLORIDE451W47IQ8X7647145INJECTION, POWDER, FOR SOLUTIONINTRAPERITONEAL226 mg
SODIUM CHLORIDE451W47IQ8X7647145SOLUTIONINTRAPERITONEAL0.54 %w/v
SODIUM CHLORIDE451W47IQ8X7647145INJECTION, POWDER, FOR SOLUTIONINTRAPLEURAL226 mg
SODIUM CHLORIDE451W47IQ8X7647145INJECTIONINTRASYNOVIAL0.9 %w/v
SODIUM CHLORIDE451W47IQ8X7647145INJECTION, SUSPENSIONINTRASYNOVIAL4 mg
SODIUM CHLORIDE451W47IQ8X7647145INJECTIONINTRATHECAL9 mg
SODIUM CHLORIDE451W47IQ8X7647145INJECTION, POWDER, FOR SOLUTIONINTRATHECAL1.35 mg
SODIUM CHLORIDE451W47IQ8X7647145INJECTION, SOLUTIONINTRATHECAL131 mg
SODIUM CHLORIDE451W47IQ8X7647145INJECTIONINTRATUMOR1.2 %w/v
SODIUM CHLORIDE451W47IQ8X7647145SUSPENSIONINTRATYMPANIC2 mg
SODIUM CHLORIDE451W47IQ8X7647145INJECTIONINTRAVASCULAR0.86 %w/v
SODIUM CHLORIDE451W47IQ8X7647145SOLUTIONINTRAVASCULARNA
SODIUM CHLORIDE451W47IQ8X7647145INJECTIONINTRAVENOUS28773 mg
SODIUM CHLORIDE451W47IQ8X7647145INJECTION, EMULSIONINTRAVENOUS0.62 %w/v
SODIUM CHLORIDE451W47IQ8X7647145INJECTION, POWDER, FOR SOLUTIONINTRAVENOUS2922 mg
SODIUM CHLORIDE451W47IQ8X7647145INJECTION, POWDER, LYOPHILIZED, FOR SOLUTIONINTRAVENOUS1800 mg
SODIUM CHLORIDE451W47IQ8X7647145INJECTION, SOLUTIONINTRAVENOUS2916 mg
SODIUM CHLORIDE451W47IQ8X7647145INJECTION, SOLUTION, CONCENTRATEINTRAVENOUS0.86 %w/v
SODIUM CHLORIDE451W47IQ8X7647145INJECTION, SUSPENSIONINTRAVENOUS0.9 %w/v
SODIUM CHLORIDE451W47IQ8X7647145LIQUIDINTRAVENOUS6320 mg
SODIUM CHLORIDE451W47IQ8X7647145SOLUTIONINTRAVENOUS90 mg
SODIUM CHLORIDE451W47IQ8X7647145INJECTION, SOLUTIONINTRAVESICAL351 mg
SODIUM CHLORIDE451W47IQ8X7647145INJECTIONINTRAVITREAL10 %w/v
SODIUM CHLORIDE451W47IQ8X7647145INJECTION, SUSPENSIONINTRAVITREAL6 mg
SODIUM CHLORIDE451W47IQ8X7647145SOLUTIONIONTOPHORESIS0.6 %w/v
SODIUM CHLORIDE451W47IQ8X7647145SYSTEMIONTOPHORESIS3.1 mg
SODIUM CHLORIDE451W47IQ8X7647145DROPSNASALNA
SODIUM CHLORIDE451W47IQ8X7647145JELLYNASALNA
SODIUM CHLORIDE451W47IQ8X7647145LIQUIDNASAL7.4 mg/1ml
SODIUM CHLORIDE451W47IQ8X7647145SOLUTIONNASAL330 mg
SODIUM CHLORIDE451W47IQ8X7647145SPRAYNASAL30 mg
SODIUM CHLORIDE451W47IQ8X7647145SPRAY, METEREDNASAL36 mg
SODIUM CHLORIDE451W47IQ8X7647145DROPSOPHTHALMIC0.08 %w/w
SODIUM CHLORIDE451W47IQ8X7647145GELOPHTHALMIC0.9 %w/v
SODIUM CHLORIDE451W47IQ8X7647145POWDER, FOR SOLUTIONOPHTHALMIC0.9 %w/w
SODIUM CHLORIDE451W47IQ8X7647145SOLUTIONOPHTHALMIC13 mg
SODIUM CHLORIDE451W47IQ8X7647145SOLUTION/ DROPSOPHTHALMIC55 mg
SODIUM CHLORIDE451W47IQ8X7647145SUSPENSIONOPHTHALMIC10 mg
SODIUM CHLORIDE451W47IQ8X7647145SUSPENSION/ DROPSOPHTHALMIC3 mg